|
Clinical properties
|
Total
|
HPV status (n/%)
|
|---|
|
Negative (%)
|
Positive (%)
|
P value
|
|---|
|
Gender
|
|
Male
|
78
|
42(62.7 %)
|
36(64.3 %)
|
0.855
|
|
Female
|
45
|
25(37.3 %)
|
20(35.7 %)
|
|
Age (mean)
|
|
<57
|
55
|
29(43.9 %)
|
26(47.3 %)
|
0.714
|
|
≥57
|
66
|
37(56.1 %)
|
29(52.7 %)
|
|
Histopathological gradea
|
|
Well
|
28
|
15(22.4 %)
|
13(23.6 %)
|
0.937
|
|
Moderate
|
77
|
42(62.7 %)
|
35(63.6 %)
|
|
Poor
|
17
|
10(14.9)
|
7(12.7 %)
|
|
Invasion depth
|
|
T1-T2
|
59
|
37(55.2 %)
|
22(40.0 %)
|
0.094
|
|
T3-T4
|
63
|
30(44.8 %)
|
33(60.0 %)
|
|
Lymphatic invasion
|
|
N0
|
55
|
28(43.8 %)
|
27(50.9 %)
|
0.438
|
|
N1-N3
|
62
|
36(56.2 %)
|
26(49.1 %)
|
|
TNM Staging
|
|
I/II
|
74
|
40(61.5 %)
|
34(65.4 %)
|
0.668
|
|
III/IV
|
43
|
25(38.5 %)
|
18(34.6 %)
|
-
a Well differentiation vs. moderate + poor differentiation
